Federica Sala

MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice

Federica Sala, Juan Aranda, Noemí Rotllán et al. · Thrombosis and Haemostasis · 2014 · 107 citations · Full text

Life Sciences, Cardiology, Molecular Medicine +17

Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib

Massimo Zucchetti, Katiuscia Bonezzi, Roberta Frapolli et al. · Cancer Chemotherapy and Pharmacology · 2013 · 40 citations

Medicine, Oncology, Pharmacology +12

Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I study

Federica Sala, Massimo Zucchetti, Renzo Bagnati et al. · Journal of Chromatography B · 2009 · 29 citations

Pharmacy, Oncology, Pharmacology +14

Simultaneous determination of gemcitabine and its main metabolite, dFdU, in plasma of patients with advanced non‐small‐cell lung cancer by high‐performance liquid chromatography‐tandem mass spectrometry

Elena Marangon, Federica Sala, Orazio Caffo et al. · Journal of Mass Spectrometry · 2007 · 29 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Peak inflammation in atherosclerosis, primary biliary cirrhosis and autoimmune arthritis is counter-intuitively associated with regulatory T cell enrichment

Stefano Garetto, Anna Elisa Trovato, Ana Lleò et al. · Immunobiology · 2015 · 24 citations · Full text

Life Sciences, Immunology, Pathology +17